Wedbush raised the firm’s price target on Kiniksa (KNSA) to $44 from $38 and keeps an Outperform rating on the shares. The firm says the company heads into Q3 earnings on the heels of another strong quarter that further reinforced Arcalyst’s durable growth trajectory in recurrent pericarditis.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KNSA: